David A. Siegel Tricida, Inc. Transaction History

Two Sigma Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.14 - $12.49 $22,064 - $1.97 Million	-157,600 Reduced 32.73%	323,900 $48,000
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $1.04 Million - $1.66 Million	122,200 Added 34.01%	481,500 $5.05 Million
Q2 2022 Aug 15, 2022	BUY	$7.31 - $11.85 $541,671 - $878,085	74,100 Added 25.98%	359,300 $3.48 Million
Q1 2022 May 16, 2022	BUY	$7.35 - $10.63 $588,000 - $850,400	80,000 Added 38.99%	285,200 $2.34 Million
Q4 2021 Feb 14, 2022	BUY	$4.19 - $9.56 $349,865 - $798,260	83,500 Added 68.61%	205,200 $1.96 Million
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $919,548 - $1.2 Million	-258,300 Reduced 67.97%	121,700 $565,000
Q2 2021 Aug 16, 2021	SELL	$3.95 - $5.41 $1.49 Million - $2.05 Million	-378,400 Reduced 49.89%	380,000 $1.64 Million
Q1 2021 May 17, 2021	BUY	$4.52 - $7.8 $2.48 Million - $4.27 Million	548,007 Added 260.47%	758,400 $4.01 Million
Q4 2020 Feb 16, 2021	BUY	$4.37 - $9.46 $364,864 - $789,843	83,493 Added 65.79%	210,393 $1.48 Million
Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $678,808 - $2.14 Million	79,300 Added 166.6%	126,900 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $506,919 - $754,045	23,900 Added 100.84%	47,600 $1.31 Million
Q1 2020 May 15, 2020	BUY	$18.43 - $38.04 $436,791 - $901,548	23,700 New	23,700 $521,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.